143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
BACE-Inhibitor successfully tested in Alzheimer's animal model

BACE-Inhibitor successfully tested in Alzheimer's animal model

by Technical University MunichMarc Aurel Busche at the two-photon microscope, which allows to visualize nerve cells with high temporal and spatial resolution in the intact brain. Credit: Kurt Bau

BACE-Inhibitor successfully tested in Alzheimer's animal model

by Technical University MunichMarc Aurel Busche at the two-photon microscope, which allows to visualize nerve cells with high temporal and spatial resolution in the intact brain. Credit: Kurt Bau
Photobiomodulation for Alzheimer's disease with modulated 1070-nm light

Photobiomodulation for Alzheimer's disease with modulated 1070-nm light

by Light Publishing Center, Changchun Institute of Optics, Fine Mechanics And Physics, CASa. The 1070-nm light irradiation apparatus and the transmittances of 1070-nm light. b. typical swimming path o

Photobiomodulation for Alzheimer's disease with modulated 1070-nm light

by Light Publishing Center, Changchun Institute of Optics, Fine Mechanics And Physics, CASa. The 1070-nm light irradiation apparatus and the transmittances of 1070-nm light. b. typical swimming path o
Alzheimer's disease and the holidays

Alzheimer's disease and the holidays

by Graciela Gutierrez,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainThe holidays can be a special time, but may present challenges for those with dementia and their loved ones. Tra

Alzheimer's disease and the holidays

by Graciela Gutierrez,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainThe holidays can be a special time, but may present challenges for those with dementia and their loved ones. Tra
AsEH enzyme: A new pharmacological target against Alzheimer's disease

AsEH enzyme: A new pharmacological target against Alzheimer's disease

by University of BarcelonaCredit: Unsplash/CC0 Public DomainA UB study published in the journalNeurotherapeuticshas validated a new pharmacological target for Alzheimer's disease.

AsEH enzyme: A new pharmacological target against Alzheimer's disease

by University of BarcelonaCredit: Unsplash/CC0 Public DomainA UB study published in the journalNeurotherapeuticshas validated a new pharmacological target for Alzheimer's disease.
How ApoE4 endangers the brain

How ApoE4 endangers the brain

by Max Delbrück Center for Molecular MedicineCredit: CC0 Public DomainApolipoprotein E (ApoE) is kind of like a delivery service for the human brain. It supplies neurons with important nutrients,

How ApoE4 endangers the brain

by Max Delbrück Center for Molecular MedicineCredit: CC0 Public DomainApolipoprotein E (ApoE) is kind of like a delivery service for the human brain. It supplies neurons with important nutrients,
AEDs tied to higher pneumonia risk in Alzheimer patients

AEDs tied to higher pneumonia risk in Alzheimer patients

(HealthDay)—Antiepileptic drug (AED) use may increase the risk for pneumonia in patients with Alzheimer disease (AD), according to a study recently published in theJournal of Alzheimer's Dis

AEDs tied to higher pneumonia risk in Alzheimer patients

(HealthDay)—Antiepileptic drug (AED) use may increase the risk for pneumonia in patients with Alzheimer disease (AD), according to a study recently published in theJournal of Alzheimer's Dis
App promises to improve pain management for dementia patients

App promises to improve pain management for dementia patients

by Katie Willis,University of AlbertaCredit: CC0 Public DomainUniversity of Alberta computing scientists are developing an app to help health-care staff assess and manage pain in patients with d

App promises to improve pain management for dementia patients

by Katie Willis,University of AlbertaCredit: CC0 Public DomainUniversity of Alberta computing scientists are developing an app to help health-care staff assess and manage pain in patients with d
AAIC: Turnover kinetics vary for different amyloid beta isoforms

AAIC: Turnover kinetics vary for different amyloid beta isoforms

(HealthDay)—Amyloid beta (Aβ)38 has faster turnover kinetics than Aβ40 and Aβ42, according to a study published online July 19 inAlzheimer's & Dementiato coincide with presentation

AAIC: Turnover kinetics vary for different amyloid beta isoforms

(HealthDay)—Amyloid beta (Aβ)38 has faster turnover kinetics than Aβ40 and Aβ42, according to a study published online July 19 inAlzheimer's & Dementiato coincide with presentation
Under 50 and overweight? Your odds for dementia later may rise

Under 50 and overweight? Your odds for dementia later may rise

by Alan Mozes, Healthday Reporter(HealthDay)—Need fresh motivation to lose some weight? New research suggests that young adults who are overweight or obese face a higher risk for dementia in their gol

Under 50 and overweight? Your odds for dementia later may rise

by Alan Mozes, Healthday Reporter(HealthDay)—Need fresh motivation to lose some weight? New research suggests that young adults who are overweight or obese face a higher risk for dementia in their gol
Rocky start for Alzheimer's drug research in 2018

Rocky start for Alzheimer's drug research in 2018

An Alzheimer sufferer models a creation by designer Guio Di Colombia during the Walkway Inclusion fashion show in Colombia last NovemberThe year 2018, barely underway, has already dealt a series of di

Rocky start for Alzheimer's drug research in 2018

An Alzheimer sufferer models a creation by designer Guio Di Colombia during the Walkway Inclusion fashion show in Colombia last NovemberThe year 2018, barely underway, has already dealt a series of di
BMI1, a promising gene to protect against Alzheimer's disease

BMI1, a promising gene to protect against Alzheimer's disease

by Julie Gazaille,University of MontrealHealthy neurons (left) and Alzheimer's disease neurons (right): in green, accumulation of G4 structures in Alzheimer’s neurons. Credit: University of

BMI1, a promising gene to protect against Alzheimer's disease

by Julie Gazaille,University of MontrealHealthy neurons (left) and Alzheimer's disease neurons (right): in green, accumulation of G4 structures in Alzheimer’s neurons. Credit: University of
AAN recommends people 65+ be screened yearly for memory problems

AAN recommends people 65+ be screened yearly for memory problems

by American Academy of NeurologyCredit: Public DomainPeople with mild cognitive impairment have thinking and memory problems but usually do not know it because such problems are not severe enough

AAN recommends people 65+ be screened yearly for memory problems

by American Academy of NeurologyCredit: Public DomainPeople with mild cognitive impairment have thinking and memory problems but usually do not know it because such problems are not severe enough